朱天宇,陈学智

• 1:北京大学国际医院心血管内科

摘要(Abstract)：

双向格林(Glenn)术是先天性心脏病的一种手术治疗方式,部分患者在术后需要植入起搏器,由于此时上腔静脉经右心房的传统入径缺失,植入起搏器需要其他不同的入径。本文介绍了目前已知的几种相关入径,它们有各自的特点,分别适用于不同的临床情况,但均未成为操作常规。因此,双向Glenn术后的起搏器入径目前仍需要根据实际情况进行个体化选择。

关键词(KeyWords)： 先天性心脏病;双向格林术;起搏器;无导线起搏器

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 朱天宇,陈学智

参考文献(References)：

• [1]Malhotra SP,Reddy VM,Qiu M,et al.The hemi-Mustard/bidirectional Glenn atrial switch procedure in the double-switch operation for congenitally corrected transposition of the great arteries:rationale and midterm results.J Thorac Cardiovasc Surg,2011,141(1):162-170.
• [2]Alenius Dahlqvist J,Sunnegardh J,Hanseus K,et al.Pacemaker treatment after Fontan surgery-A Swedish national study.Congenit Heart Dis,2019,14(4):582-589.
• [3]Huntley GD,Deshmukh AJ,Warnes CA,et al.Longitudinal outcomes of epicardial and endocardial pacemaker leads in the adult fontan patient.Pediatr Cardiol,2018,39(7):1476-1483.
• [4]Takahashi K,Cecchin F,Fortescue E,et al.Permanent atrial pacing lead implant route af ter fontan operation.Pacing Clin Electrophysiol,2009,32(6):779-785.
• [5]Fortescue EB,Berul CI,Cecchin F,et al.Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients.J Interv Card Electrophysiol,2005,14(1):27-36.
• [6]Barakat K,Hill J,Kelly P.Permanent transfemoral pacemaker implantation is the technique of choice for patients in whom the superior vena cava is inaccessible.Pacing Clin Electrophysiol,2000,23(4 Pt 1):446-449.
• [7]Mathur G,Stables RH,Heaven D,et al.Permanent pacemaker implantation via the femoral vein:an alternative in cases with contraindications to the pectoral approach.Europace,2001,3(1):56-59.
• [8]Harake DE,Shannon KM,Aboulhosn JA,et al.Transvenous pacemaker implantation after the bidirectional Glenn operation f or patients with complex congenital disease.J Cardiovasc Electrophysiol,2018,29(3):497-503.
• [9]West JN,Shearmann CP,Gammage MD.Permanent pacemaker positioning via the inferior vena cava in a case of single ventricle with loss of right atrial-vena cava continuity.Pacing Clin Electrophysiol,1993,16(8):1753-1755.
• [10]Patel MB,Punnam SR,Gupta AK,et al.Post Glenn shunt:how to pace?Pacing Clin Electrophysiol,2007,30(5):672-674.
• [11]Fishberger SB,Camunas J,Rodriguez-Fernandez H,et al.Permanent pacemaker lead implantation via the transhepatic route.Pacing Clin Electrophysiol,1996,19(7):1124-1125.
• [12]Wei J,Xu Y,Fang Y.Percutaneous trans-hepatic route for dual chamber pacemaker implantation in a patient with post-Glenn operation.J Cardiovasc Electrophysiol,2017,28(8):956-957.
• [13]Singhi A,Sheriff EA,Sivakumar K.Transhepatic permanent pacing in a child with complex cyanotic heart disease after total cavo pulmonary shunt (Kawashima repair).Indian Pacing Electrophysiol J,2016,16(2):73-76.
• [14]Umamaheshwar KL,Singh AS,Sivakumar K.Endocardial transvenous pacing in patients with surgically palliated univentricular hear ts:A review on dif f erent techniq ues,problems and management.Indian Pacing Electrophysiol J,2019,19(1):15-22.
• [15]Johnsrude CL,Backer CL,Deal BJ,et al.Transmural atrial pacing in patients with postoperative congenital heart disease.J Cardiovasc Electrophysiol,1999,10(3):351-357.
• [16]Williams MR,Shepard SM,Boramanand NK,et al.Longterm follow-up shows excellent transmural atrial lead performance in patients with complex congenital heart disease.Circ Arrhythm Electrophysiol,2014,7(4):652-657.
• [17]Habib M,Hillis M,Hasira MA,et al.Cardiac permanent pacing after a correction of a congenital heart defect.J Case Rep Stud,2016,4(2):209.
• [18]Seipelt RG,Franke A,Vazquez-Jimenez JF,et al.Thromboembolic complications after Fontan procedures:comparison of different therapeutic approaches.Ann Thorac Surg,2002,74(2):556-562.
• [19]Arif S,Clift PF,De Giovanni JV.Permanent trans-venous pacing in an extra-cardiac Fontan circulation.Europace,2016,18(2):304-307.
• [20]Kirkfeldt RE,Johansen JB,Nohr EA,et al.Complications after cardiac implantable electronic device implantations:an analysis of a complete,nationwide cohort in Denmark.Eur Heart J,2014,35(18):1186-1194.
• [21]Bernard ML.Pacing without wires:leadless cardiac pacing.Ochsner J,2016,16(3):238-242.
• [22]Reddy VY,Knops RE,Sperzel J,et al.Permanent leadless cardiac pacing:results of the LEADLESS trial.Circulation,2014,129(14):1466-1471.
• [23]Tjong FVY,Knops RE,Neuzil P,et al.Midterm safety and performance of a leadless cardiac pacemaker:3-year follow-up to the LEADLESS trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System).Circulation,2018,137(6):633-635.
• [24]Reddy VY,Exner DV,Cantillon DJ,et al.Percutaneous implantation of an entirely intracardiac leadless pacemaker.N Engl J Med,2015,373(12):1125-1135.
• [25]Lee JZ,Mulpuru SK,Shen WK.Leadless pacemaker:performance and complications.Trends Cardiovasc Med,2018,28(2):130-141.
• [26]Piccini JP,Stromberg K,Jackson KP,et al.Long-term outcomes in leadless micra transcatheter pacemakers with elevated thresholds at implantation:results from the micra transcatheter pacing system global clinical trial.Heart Rhythm,2017,14(5):685-691.
• [27]Duray GZ,Ritter P,El-Chami M,et al.Long-term performance of a transcatheter pacing system:12-month results from the micra transcatheter pacing study.Heart Rhythm,2017,14(5):702-709.
• [28]Tjong FV,Brouwer TF,Smeding L,et al.Combined leadless pacemaker and subcutaneous implantable defibrillator therapy:feasibility,safety,and performance.Europace,2016,18(11):1740-1747.
• [29]Auricchio A,Delnoy PP,Butter C,et al.Feasibility,safety,and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients:results of the wireless stimulation endocardially for CRT (Wi SE-CRT) study.Europace,2014,16(5):681-688.
• [30]Reddy VY,Miller MA,Neuzil P,et al.Cardiac resynchronization therapy with wireless lef t ventricular endocardial pacing:the SELECT-LV study.J Am Coll Cardiol,2017,69(17):2119-2129.